Carlo Irace

Via D. Montesano 49
Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

F2F-202, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor, Behaves as an Arrow with Multiple Tips against Azole-Resistant C. albicans: Modulation of Yeast-to-Hyphae Transition, Trailing Effect, and Oxidative Stress.

F2F-202, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor, Behaves as an Arrow with Multiple Tips against Azole-Resistant C. albicans: Modulation of Yeast-to-Hyphae Transition, Trailing Effect, and Oxidative Stress.

Journal: ACS infectious diseases

Published: May 22, 2026

Upcycling lemon peel waste into sustainable bioactive ingredients: chemical characterization and efficacy assessment.

Upcycling lemon peel waste into sustainable bioactive ingredients: chemical characterization and efficacy assessment.

Journal: The Analyst

Published: May 11, 2026

Repositioning of 3-(isoxazol-3-yl)thiazolidin-4-one-based compounds via Inverse Virtual Screening: discovery of new ERα inhibitors with in vitro activity in breast cancer models.

Repositioning of 3-(isoxazol-3-yl)thiazolidin-4-one-based compounds via Inverse Virtual Screening: discovery of new ERα inhibitors with in vitro activity in breast cancer models.

Journal: European journal of medicinal chemistry

Published: February 24, 2026

Modulating STAT3 pathway in breast cancer: Improved activity of T40214 aptamer by peptide-based nanofibers delivering.

Modulating STAT3 pathway in breast cancer: Improved activity of T40214 aptamer by peptide-based nanofibers delivering.

Journal: International journal of biological macromolecules

Published: January 22, 2026

Correction: MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction.

Correction: MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 06, 2025

Design and evaluation of dual-functional aptamer-peptide conjugates as a platform for targeted cancer therapy.

Design and evaluation of dual-functional aptamer-peptide conjugates as a platform for targeted cancer therapy.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: November 06, 2025

Valorization of Citrus industry by-products through supercritical CO₂ extraction of natural compounds.

Valorization of Citrus industry by-products through supercritical CO₂ extraction of natural compounds.

Journal: Analytical and bioanalytical chemistry

Published: August 01, 2025

MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction.

MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 23, 2025

Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer.

Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer.

Journal: Pharmaceutics

Published: June 18, 2025

Erratum: miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma.

Erratum: miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma.

Journal: Molecular therapy. Nucleic acids

Published: April 10, 2025

Valorization of Arbutus unedo L. Pomace: Exploring the Recovery of Bioactive Phenolic Compounds from Distillation By-Products.

Valorization of Arbutus unedo L. Pomace: Exploring the Recovery of Bioactive Phenolic Compounds from Distillation By-Products.

Journal: Antioxidants (Basel, Switzerland)

Published: February 03, 2025

Design, Synthesis, and Anticancer Activity of Drug-like Iron Chelators/G-Quadruplex Binders as Synergic Dual Targeting Agents.

Design, Synthesis, and Anticancer Activity of Drug-like Iron Chelators/G-Quadruplex Binders as Synergic Dual Targeting Agents.

Journal: Journal of medicinal chemistry

Published: January 01, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026